For a patient with metastatic, poorly differentiated esophageal adenocarcinoma with an excellent systemic response to chemotherapy for 1 year, who now presents with isolated local progression and no new distant disease: Would you consider treating the primary site with a higher palliative dose for more durable control?

Would you consider a dose such as 40 Gy in 15 fx vs. a more standard palliative dose?